STAT April 28, 2022
Damian Garde, Meg Tirrell and Adam Feuerstein

Can rewired cells cure some patients’ cancer? Do biotech stocks ever go up? And why’s it taking so long to get kids vaccinated for Covid-19?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Immunologist Katy Rezvani of MD Anderson Cancer Center joins us to explain the massive potential of a new approach to treating wily tumors, one that repurposes human immune cells. We also discuss the latest news in the life sciences, including an interesting hire at Novartis, the pediatric Covid-19 vaccine saga, and another negative...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Conferences / Podcast, FDA, Govt Agencies, Pharma / Biotech, Trends
Related Articles:
Former Bristol Myers CEO tapped as Novartis’ next board chair
The Power of Drug Discovery with Philip Tagari
Novartis raises forecasts as top drug sales beat Wall Street estimates
Pharma Pulse 4/23/24: Drug Discount Programs Poised to Change with New Tech, SpecialtyRx Savings Navigator to Enhance Affordability & more
AI Ushers in HPC Revival Says TACC’s Dan Stanzione

Share This Article